Chairman Jim Coleman accepts Erlanger CEO position

Jim Coleman, chairman of the Erlanger Health System Board of Trustees, will leave that position and take over as the health system's president and CEO effective July 11.

In a letter sent Friday morning to Erlanger employees, Coleman announced he had accepted the board's one-year, $625,000 contract offer to assume the CEO role vacated by former CEO Dr. Will Jackson, who left Erlanger on June 10.

The contract was presented and unanimously approved at a public board meeting Thursday evening.

"The opportunity to serve and lead this organization is deeply meaningful to me. Being from Cleveland, Tennessee, and working a significant portion of my career in this market, I personally know how important Erlanger Health System is to our community and the broader region," Coleman said in the letter.